Loading company…
MedySapiens develops diagnostic solutions using bioinformatics and artificial intelligence.
Founded in 2016 and based in Seoul, MedySapiens uses bioinformatics and artificial intelligence to develop solutions for early diagnosis of rare genetic diseases in newborns. Its products include skin assessment software and genetic testing panels for treatment and diagnostic guidance. In March 2022, it raised KRW 7 billion in Series A funding from Korea Venture Investment Corporation, L&S Venture Capital, Vision Creator, and an unspecified investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in